Suggested Topics within your search.
Suggested Topics within your search.
- Historiography 2
- Information technology 2
- Internet in public administration 2
- Neonatal Intensive Care 2
- Northern Thai language 2
- Public administration 2
- Readers 2
- Christianity 1
- Content analysis (Communication) 1
- Cooking 1
- Dermatopathology 1
- Desertions 1
- Diagnostic Pathology 1
- History 1
- Intelligence service 1
- Mass media 1
- Moral and ethical aspects 1
- Psychology, Pathological 1
- Theology 1
- Vietnam War, 1961-1975 1
-
421
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer
Published 2025-01-01Subjects: Get full text
Article -
422
-
423
Evaluation of Renal Gene Expression of Protein Kinase C (PKC) Isoforms in Diabetic and Nondiabetic Proliferative Glomerular Diseases
Published 2008-01-01“…The protein kinase C (PKC) family consists of 13 members categorized as conventional or novel depending on whether diacylglycerol, calcium, or phosphatidylserine is required for activation. …”
Get full text
Article -
424
Clonal Propagation of Khaya senegalensis: The Effects of Stem Length, Leaf Area, Auxins, Smoke Solution, and Stockplant Age
Published 2011-01-01“…Khaya senegalensis is a multipurpose African timber species. …”
Get full text
Article -
425
Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain
Published 2014-01-01“…Diabetes mellitus (DM) and Alzheimer’s disease (AD) are characterized by amyloid deposits. Glycogen synthase kinase-3 (GSK-3) plays an important role in the pathogenesis of AD and DM. …”
Get full text
Article -
426
Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
Published 2025-02-01“…Abstract Background Non-small cell lung cancer (NSCLC) transforming to small cell lung cancer (SCLC) is one of the mechanisms of resistance to tyrosine kinase inhibitors (TKIs). Cases of NSCLC transforming into SCLC have been discovered. …”
Get full text
Article -
427
Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)
Published 2025-03-01“…A comprehensive characterization of mucocutaneous adverse events (MAEs) has not been performed; therefore, we characterized MAEs associated with the selective RET inhibitor, selpercatinib. …”
Get full text
Article -
428
HEAVY METALS IN SURFACE SEAWATER AND SEDIMENT FROM THE COAST OF KHANH HOA PROVINCE: LEVELS AND ECOLOGICAL RISK ASSESSMENT
Published 2024-09-01Subjects: Get full text
Article -
429
Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma
Published 2024-12-01“…Abstract Fibrolamellar Hepatocellular Carcinoma (FLC) is a rare liver cancer characterized by a fusion oncokinase of the genes DNAJB1 and PRKACA, the catalytic subunit of protein kinase A (PKA). A few FLC-like tumors have been reported showing other alterations involving PKA. …”
Get full text
Article -
430
The role of adenosine monophosphate-activated protein kinase and serum amyloid A proteins in the early diagnosis of neonatal sepsis
Published 2024-09-01Subjects: “…adenosine monophosphate-activated protein kinase…”
Get full text
Article -
431
Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
Published 2025-02-01“…Abstract Significant implications of glycogen synthase kinase-3β (GSK-3β) have been reported in various neuronal disorders and malignant cancers. …”
Get full text
Article -
432
Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B.
Published 2025-01-01“…It has been shown in many cancers, including breast cancer, that aberrant expression of miRNAs may be associated with drug resistance. …”
Get full text
Article -
433
Late Emergence of an Imatinib-Resistant ABL1 Kinase Domain Mutation in a Patient with Chronic Myeloid Leukemia
Published 2017-01-01“…The introduction of the tyrosine kinase inhibitor (TKI) imatinib has revolutionised the outlook of chronic myeloid leukemia (CML); however, a significant proportion of patients develop resistance through several mechanisms, of which acquisition of ABL1 kinase domain mutations is prevalent. …”
Get full text
Article -
434
De la prédation et de la chasse à l’homme à l’anarchisme universel
Published 2016-06-01Get full text
Article -
435
Nghiên cứu phân lập vi khuẩn nội sinh từ một số giống lan rừng
Published 2024-10-01“…Tạp chí Khoa học Đại học Huế: Khoa học Tự nhiên…”
Get full text
Article -
436
Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression
Published 2025-02-01“…Prostate cancer, the most common malignancy in men, has a relatively favourable prognosis. However, when it spreads to the bone, the survival rate drops dramatically. …”
Get full text
Article -
437
Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
Published 2011-01-01“…The striking point of this case story is that no Abl kinase domain mutation against TKIs has been detected during this very complicated disease course of CML. …”
Get full text
Article -
438
Le cerf chez les anciens P’urhépecha du Michoacan (Mexique) : guerre, chasse et sacrifice
Published 2008-12-01Get full text
Article -
439
Rôle de la cueillette, la pêche et la chasse dans l’alimentation au Laos
Published 2012-12-01Get full text
Article -
440
RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
Published 2019-12-01“… B-RAF is a one of the RAF protein kinase group that contribute to the development of different types of cancer. …”
Get full text
Article